Federated Hermes, Inc. Oyster Point Pharma, Inc. Transaction History

Federated Hermes, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.6 - $11.2 $403 - $1,254	112 New	112 $1,000
Q4 2020 Feb 12, 2021	SELL	$18.13 - $25.18 $2,211 - $3,071	-122 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$17.83 - $29.12 $2,175 - $3,552	122 New	122 $3,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.